Note: Ingredients listed on restricted chemical lists
EC/CAS
13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
N/A
General Information
Revision date
2022-02-15
Product name
REQUIP TABLETS
Product Synonyms
REQUIP 0.25 MG FILM COATED TABLETS * REQUIP 0.5 MG FILM COATED TABLETS *
1.2.2. Uses advised against
No other uses are advised
supplier name
GlaxoSmithKline UK
Emergency telephone
VERISK 3E GLOBAL INCIDENT RESPONSE
Icons in SDS
Company Information
company name
GlaxoSmithKline UK
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Warning!
Section 2
SECTION 2: Hazards identification
result in GHS classification: 2.1 GHS classification of substance or mixture, and national or regional information
Physical hazards
Not classified.
Health hazards
Not classified.
Environmental hazards
Not classified.
2.2 Label elements
Hazard symbol(s) None.
Signal word
None.
Hazard statements
The mixture does not meet the criteria for classification.
Precautionary statements
Not available. 2.3 Other hazards which do not Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health result in GHS classification hazards.
Additional information
Warning! Hazardous respirable dust may be formed when used. Do not breathe dust. 74.437 % of the mixture consists of component(s) of unknown acute oral toxicity. 88.06 % of the mixture consists of component(s) of unknown acute dermal toxicity. 84.41 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 84.41 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.
